USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/18003
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPopa, Vera
dc.contributor.authorGrosu, Oxana
dc.contributor.authorLisnic, Vitalie
dc.contributor.authorGavriliuc, Mihail
dc.contributor.authorOdainic, Olesea
dc.contributor.authorManvelov, Anastasia
dc.contributor.authorCebotari, Ecaterina
dc.date.accessioned2021-09-27T13:47:23Z
dc.date.available2021-09-27T13:47:23Z
dc.date.issued2021
dc.identifier.citationPOPA, Vera, GROSU, Oxana, LISNIC, Vitalie, GAVRILIUC, Mihail, ODAINIC, Olesea, et al. Preliminary results of the ENERGY study (Ean NEuro-covid ReGistrY) in the Republic of Moldova. In: The Moldovan Medical Journal. 2021, vol. 64, no 3 (Neuro Congress Issue), p. 22. ISSN 2537-6381.
dc.identifier.issn2537-6381
dc.identifier.issn2537-6373
dc.identifier.urihttp://moldmedjournal.md/wp-content/uploads/2021/09/Congres-Neuro-2021-Spaltul-11.pdf
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/18003
dc.description.abstractBackground: ENERGY registry developed by the European Academy of Neurology studies neurological manifestations in patients with COVID-19 infections. Diomid Gherman Institute of Neurology and Neurosurgery joined these efforts in December 2020. The aim of the study was to present the Moldovan cohort of patients with COVID-19 infection and neurological manifestations registered in the ENERGY. Material and methods: The registry recorded demographic data, comorbidities, complications, neurological symptoms in confirmed COVID-19 patients. The patients were evaluated at 6 and 12 months by phone. Results: The Moldovan cohort of patients with COVID-19 and neurological manifestations by May 2021 consists of 168 patients (50.6% men and 49.4% women). Most patients (86.9%) had comorbidities, such as arterial hypertension – 83.3%, diabetes mellitus – 23.2 %, cardiovascular – 27.4 %, obesity – 21.4 %. History of neurological diseases with impact on patient’s health was dementia 3.0%, Parkinson’s disease – 1.2%, stroke – 19.0%, multiple sclerosis – 1.2%, neuromuscular disorder – 1.2%, neuropathy – 1.8%. Complications requiring medical intervention were dyspnea – 44.6%, pneumonia – 61.9%, cardiovascular – 7.1%, renal insufficiency – 1.2%, coagulation disorder – 4.2% and mechanical ventilation – 16.1%. New neurological findings in patients with COVID-19 infection were headache (24.4%), vertigo (14.3%), cognitive impairment (35.7%), stupor/coma (22.1%), stroke (62.5%), ataxia (11.4%), spinal cord disorder (7.2%), peripheral neuropathy (5.4%). Mortality rate in the cohort was 22.61%. Conclusions: The Moldovan cohort of patients with neurological manifestations during COVID-19 infections registered in the ENERGY registry presented most frequently at the emergency department with stroke, cognitive impairment and headache. They have many comorbidities, history of neurological diseases, complications during hospital stay and high mortality rate.en_US
dc.language.isoenen_US
dc.publisherThe Scientific Medical Association of the Republic of Moldovaen_US
dc.relation.ispartofThe Moldovan Medical Journalen_US
dc.subjectENERGYen_US
dc.subjectEANen_US
dc.subjectRegistryen_US
dc.subjectNeuroCOVIDen_US
dc.titlePreliminary results of the ENERGY study (Ean NEuro-covid ReGistrY) in the Republic of Moldovaen_US
dc.typeOtheren_US
Appears in Collections:The Moldovan Medical Journal, Vol. 64, No 3, September 2021

Files in This Item:
File Description SizeFormat 
Preliminary_results_of_the_ENERGY_study_Ean_NEuro_covid_ReGistrY.pdf75.23 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback